GlassScriptPhysician profile
Michael Craig Walker
NPI 1922630128
$12,293.59
in general payments reported to CMS, 2019-2025
35 companies · $3,086 in 2025
The $3,086 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,039 · 2022: $758 · 2023: $3,436 · 2024: $3,975 · 2025: $3,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,573 · Travel and Lodging: $843 · Education: $81.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,572.68 |
| Travel and Lodging | $843.33 |
| Education | $81.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,362.42 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,604.09 | 2022-2025 | Corevalve Evolut R, Cg Future, Apollotm |
| Abiomed | $966.23 | 2024-2025 | Impella |
| Amgen INC. | $724.71 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $626.65 | 2021-2025 | Lifevest |
| Pfizer INC. | $613.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $562.91 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $534.22 | 2021-2025 | |
| Boston Scientific Corporation | $372.21 | 2021-2025 | Watchman Flx, General - Embolics, Embold Fibered |
| Boehringer Ingelheim Pharmaceuticals, INC. | $333.37 | 2021-2025 | Jardiance |
| Abbott Laboratories | $318.75 | 2025 | Navitor, Mitraclip, Triclip |
| Janssen Pharmaceuticals, INC | $279.30 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $268.99 | 2021-2025 | Lokelma, Wainua, Farxiga |
| Teleflex LLC | $268.90 | 2024 | Manta |
| Kestra Medical Technology Services, INC. | $177.35 | 2024-2025 | Assure Wcd |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $169.11 | 2021-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $161.13 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $158.51 | 2021-2025 | Amvuttra |
| Altathera Pharmaceuticals LLC | $145.45 | 2023 | Sotalol Hydrochloride |
| Cvrx, INC. | $134.97 | 2021-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $66.74 | 2022 | |
| Amarin Pharma, INC. | $57.93 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.75 | 2025 | |
| Bridgebio Pharma, INC. | $50.19 | 2025 | Attruby |
| Scpharmaceuticals INC. | $47.35 | 2023-2024 | |
| Daiichi Sankyo INC. | $36.04 | 2023 | Injectafer |
| Novo Nordisk INC | $32.41 | 2021-2022 | |
| Endotronix, INC. | $26.74 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Inari Medical, INC. | $26.24 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $25.06 | 2025 | Benchmark |
| Atricure, INC. | $23.48 | 2022 | |
| Recor Medical INC | $20.31 | 2024 | Paradise Renal Denervation System |
| Arbor Pharmaceuticals, INC. | $17.54 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $12.78 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $12.78 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.